The effect of resiquimod (a Toll-like receptor-7/8 agonist) on the balance between pro-inflammatory and anti-inflammatory cytokines in breast cancer patients

Abstract Background Breast cancer (BC) progression is influenced by both pro- and anti-inflammatory cytokines. Interleukin (IL)-12 and IL-35 play opposing immunological roles, functioning as pro- and anti-inflammatory cytokines with anti- and pro-tumorigenic effects, respectively. Resiquimod (RSQ),...

Descripció completa

Dades bibliogràfiques

Autors principals:	Eman ElAlfy, Lobna A. Abou-Shamaa, Soheir Rizk Demian, Eman M Osman, Yasmine ELwany, Marwa Mohamed Samak
Format:	Artigo
Idioma:	Inglês
Publicat:	Springer 2026-03-01
Col·lecció:	Discover Oncology
Matèries:	Breast cancer Inflammation Resiquimod TLR agonist Cytokines IL-12
Accés en línia:	https://doi.org/10.1007/s12672-026-04619-8
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!